ITP vs TTP: Key Differences, Symptoms, and Treatment
ITP (Immune Thrombocytopenia) is a chronic autoimmune disorder where antibodies attack platelets, causing low counts. TTP (Thrombotic Thrombocytopenic Purpura) is an acute clotting disorder triggered by ADAMTS13 deficiency, forming micro-clots that consume platelets and damage organs.
People Google “ITP vs TTP” at 2 a.m. because both show bruising and low platelets. The mix-up is dangerous: one needs steroids, the other emergency plasma exchange. Spotting confusion or kidney failure decides the hospital path.
Key Differences
ITP presents with isolated low platelets, petechiae, and mild mucosal bleeding; labs show high platelet antibodies. TTP adds fever, neurologic shifts, hemolytic anemia, and renal injury; blood film reveals schistocytes and extremely low ADAMTS13 activity.
Which One Should You Choose?
Choose ITP management if chronic low platelets recur with minor bleeds; steroids, IVIG, or TPO agonists fit. Choose TTP therapy if sudden confusion, dark urine, and falling hemoglobin appear—immediate plasmapheresis and rituximab save lives.
Can ITP turn into TTP?
No, they are distinct diseases; ITP does not evolve into TTP.
Do both require steroids?
Only ITP routinely uses steroids; TTP needs plasma exchange first.
How fast must TTP be treated?
Within 4–8 hours of suspected diagnosis to prevent irreversible organ damage.